AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
Agricola
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
American Journal of Clinical Nutrition, Vol. 80, No. 1, 163-170, July 2004
© 2004 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Elevated serum creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myoblasts1,2,3,4

Kerry-Ann da Costa, Mihaela Badea, Leslie M Fischer and Steven H Zeisel

1 From the Department of Nutrition, School of Public Health and School of Medicine, University of North Carolina at Chapel Hill

Background: Choline is a required nutrient, and humans deprived of choline develop liver damage.

Objective: This study examined the effect of choline deficiency on muscle cells and the release of creatine phosphokinase (CPK) as a sequela of that deficiency.

Design: Four men were fed diets containing adequate and deficient amounts of choline, and serum was collected at intervals for measurement of CPK. C2C12 mouse myoblasts were cultured in a defined medium containing 0 or 70 µmol choline/L for up to 96 h, and CPK was measured in the media; choline and metabolites were measured in cells. Apoptosis was assessed by using terminal deoxynucleotidyl transferase–mediated dUTP-biotin end labeling and activated caspase-3 immunohistochemistry. Cell fragility in response to hypo-osmotic stress was also assessed.

Results: Three of 4 humans fed a choline-deficient diet had significantly elevated serum CPK activity derived from skeletal muscle (up to 66-fold; P < 0.01) that resolved when choline was restored to their diets. Cells grown in choline-deficient medium for 72 h leaked 3.5-fold more CPK than did cells grown in medium with 70 µmol choline/L (control medium; P < 0.01). Apoptosis was induced in cells grown in choline-deficient medium. Phosphatidylcholine concentrations were diminished in choline-deficient cells (to 43% of concentrations in control cells at 72 h; P < 0.01), as were concentrations of intracellular choline, phosphocholine, and glycerophosphocholine. Cells grown in choline-deficient medium had greater membrane osmotic fragility than did cells grown in control medium.

Conclusions: Choline deficiency results in diminished concentrations of membrane phosphatidylcholine in myocytes, which makes them more fragile and results in increased leakage of CPK from cells. Serum CPK may be a useful clinical marker for choline deficiency in humans.

Key Words: Creatine phosphokinase • choline deficiency • muscle • myoblasts • apoptosis • phosphatidylcholine




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
S. H Zeisel
Importance of methyl donors during reproduction
Am. J. Clinical Nutrition, February 1, 2009; 89(2): 673S - 677S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Veenema, C. Solis, R. Li, W. Wang, C. V Maletz, C. M Abratte, and M. A Caudill
Adequate Intake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load
Am. J. Clinical Nutrition, September 1, 2008; 88(3): 685 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Solis, K. Veenema, A. A. Ivanov, S. Tran, R. Li, W. Wang, D. J. Moriarty, C. V. Maletz, and M. A. Caudill
Folate Intake at RDA Levels Is Inadequate for Mexican American Men with the Methylenetetrahydrofolate Reductase 677TT Genotype
J. Nutr., January 1, 2008; 138(1): 67 - 72.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. H Zeisel
Nutrigenomics and metabolomics will change clinical nutrition and public health practice: insights from studies on dietary requirements for choline
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 542 - 548.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Resseguie, J. Song, M. D. Niculescu, K.-A. da Costa, T. A. Randall, and S. H. Zeisel
Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes
FASEB J, August 1, 2007; 21(10): 2622 - 2632.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. M Fischer, K. A. daCosta, L. Kwock, P. W Stewart, T.-S. Lu, S. P Stabler, R. H Allen, and S. H Zeisel
Sex and menopausal status influence human dietary requirements for the nutrient choline
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1275 - 1285.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. H. Zeisel
Response to: DEA in consumer products is safe
FASEB J, January 1, 2007; 21(1): 296 - 297.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K.-A. da Costa, M. D Niculescu, C. N Craciunescu, L. M Fischer, and S. H Zeisel
Choline deficiency increases lymphocyte apoptosis and DNA damage in humans
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 88 - 94.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K.-A. da Costa, O. G. Kozyreva, J. Song, J. A. Galanko, L. M. Fischer, and S. H. Zeisel
Common genetic polymorphisms affect the human requirement for the nutrient choline
FASEB J, July 1, 2006; 20(9): 1336 - 1344.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kohlmeier, K.-A. da Costa, L. M. Fischer, and S. H. Zeisel
Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans
PNAS, November 1, 2005; 102(44): 16025 - 16030.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. H Zeisel
Choline, homocysteine, and pregnancy
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 719 - 720.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K.-A. da Costa, C. E Gaffney, L. M Fischer, and S. H Zeisel
Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 440 - 444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition